Boardroom Alpha
Start trial
Research library
SPACs · Oct 20, 2026

SPAC Market Update October 20, 2026: QuartzSea Extends with $35 million Redemptions

Apogee Acquisition Corp (AACP) filed a non-reliance 8-K on October 20, 2026, covering previously issued financial statements; Quartzsea Acquisition Corp (QSEA) had $35,824,275 removed from trust after its October 20, 2026 extension vote. QSEA extended its…

SPAC IPO Update — October 20, 2026

No SPAC IPOs priced on October 20, 2026; October MTD now stands at 4 IPOs totaling $491M over 20 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 4•Prior: 5•MoM: -1
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
19
Jun ’26
18
Jul ’26
12
Aug ’26
5
Sep ’26
4
Oct ’26
Source: Boardroom Alpha
IPO Activity SnapshotMonth-to-date: 4 IPOs ($491M) vs. first 20 days of last month 3 ($538M) · 12-mo avg: 16/mo
$ totals include underwriter over-allotment.
New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Oct 16 TCXB TCGX ACQUISITION CORP II $100M 100.0%
Oct 14 FLSC FRAZIER LIFE SCIENCES ACQUISITION CORP II $75M 100.0%
Source: Boardroom Alpha

Daily SPAC Update — October 20, 2026

SPAC VOTE RESULTS
QUARTZSEA ACQUISITION CORP (QSEA) * Extend to February 19, 20273,344,937 redeemed · $35,824,275 removed · trust $10.71

SPAC DEALS ANNOUNCED
October 19 | Tcgx Acquisition Corp (TCGX) + TriGemX BioTriGemX Bio is a biotechnology company developing elismetrep, a potential first-in-class TRPM8 channel blocker aimed at treating migraines. The company’s research focuses on neural signaling pathways, particularly targeting the trigeminal ganglion, where TRPM8 is expressed. Elismetrep is currently undergoing Phase 3 trials for acute migraine treatment, with initial results expected in mid-2027.
October 15 | Pyrophyte Acquisition Corp II (PAII) + Sakuu CorpSakuu Corp provides commercial-scale printing equipment and technologies for manufacturers of batteries, electrodes, and supercapacitors. Its Kavian Platform enables dry printing of battery electrodes, promoting rapid manufacturing while reducing costs and waste. Headquartered in Silicon Valley, it focuses on sustainable manufacturing solutions.

SPAC DEAL & EXTENSION VOTES SET
Kochav Defense Acquisition Corp (KCHV) * EXTENSION VOTE SET: November 13, 2026 * trust $10.53
Aimei Health Technology Co Ltd (AFJK) * EXTENSION VOTE SET: November 10, 2026 * trust $12.25

EXTENSION VOTES
BOLD EAGLE ACQUISITION CORP (BEAG)vote October 20, 2026 -> extend from October 25, 2026 to June 25, 2027

SPAC EXTENSIONS
WINVEST ACQUISITION CORP (WINV) * Extension FilingSponsor provides second $30k loan to extend SPAC deadline. Funds added to the trust will support redemption or liquidation payouts.

OTHER SPAC NEWS
CSLM DIGITAL ASSET ACQUISITION CORP III LTD (KOYN) * Media TranscriptKOYN announces a deal with First Digital. SPAC investor-relations focus; down round disclosed.
TCGX ACQUISITION CORP (TCGX) * Merger Agreement
TCGX ACQUISITION CORP (TCGX) * Investor Deck

SPAC NON-RELIANCE 8-K
Apogee Acquisition Corp (AACP) : Non-Reliance on Previously Issued Financials

SPAC Executive & Director Moves — October 20, 2026

SPAC Executive & Director Moves
Company Ticker Moves
APOGEE ACQUISITION CORP AACP
  • Anna Brunelle resigned as a Director effective October 13, 2026, leaving the Board and its audit and compensation committees. Christopher Valentine, already a Director, was appointed to the audit committee on October 14, 2026, and Tom Watson resigned as Chief Operating Officer effective October 14, 2026.  (view source)
TCGX ACQUISITION CORP II TCXB
  • On October 15, 2026, Joshua Cohen, Mark McKenna, and Dr. Michael Henderson were appointed as independent directors, with each joining the Audit and Compensation Committees; Henderson became Audit Committee chair and McKenna became Compensation Committee chair. Chen Yu and Craig Skaling resigned from the Board upon completion of the IPO.  (view source)
Source: SEC EDGAR filings via Boardroom Alpha

SPAC Movers — October 20, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
QUETTA ACQUISITION CORP QETA 3.1% $ 11.55 Announced
SILVERBOX CORP IV SBXD 2.6% $ 11.39 Announced
CALISA ACQUISITION CORP ALIS 2.4% $ 9.06 Announced
RISING DRAGON ACQUISITION CORP RDAC 2.2% $ 5.00 Announced
XFLH CAPITAL CORP XFLH 1.2% $ 10.21 Pre-Deal
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
BLACK HAWK ACQUISITION CORP BKHA -32.9% $ 4.03 Announced
TCGX ACQUISITION CORP TCGX -18.5% $ 10.02 Announced
ARCHIMEDES TECH SPAC PARTNERS II CO ATII -8.0% $ 8.55 Announced
RESEARCH ALLIANCE CORP IV RACD -5.2% $ 10.67 Pre-Deal
TCGX ACQUISITION CORP II TCXB -4.2% $ 10.40 Pre-Deal
Source: Boardroom Alpha market data

Frequently Asked Questions

  • What did Apogee Acquisition Corp disclose on October 20, 2026?
    Apogee Acquisition Corp (AACP) filed a non-reliance 8-K covering previously issued financial statements. The same company also reported board and officer changes effective October 13 and October 14, 2026.
  • How much was redeemed at Quartzsea Acquisition Corp’s extension vote?
    Quartzsea Acquisition Corp (QSEA) had 3,344,937 shares redeemed, removing $35,824,275 from trust at $10.71 per share. The extension moved the SPAC’s deadline to February 19, 2027.
  • How many SPAC IPOs priced in October 2026 through October 20?
    4 SPAC IPOs priced for $491M through October 20, 2026, compared with 3 IPOs for $538M over the first 20 days of September 2026.
  • Which SPAC extension votes were set today?
    Kochav Defense Acquisition Corp (KCHV) set a November 13, 2026 extension vote, and Aimei Health Technology Co Ltd (AFJK) set a November 10, 2026 extension vote.
  • What deadline extension did Bold Eagle Acquisition Corp put to shareholders?
    Bold Eagle Acquisition Corp (BEAG) held an October 20, 2026 extension vote to move its deadline from October 25, 2026 to June 25, 2027.


Go deeper

SPAC data & trackers

Get it in your inbox

The Daily SPAC Update in your inbox

Every IPO, vote, and DeSPAC close — analyzed daily for finance professionals.

ShareXLinkedIn

Published Oct 20, 2026

More from SPACs

All research
SPACs · Oct 19, 2026

SPAC Market Update October 19, 2026: TCGX to Merge with TriGemX Bio

Tcgx Acquisition Corp (TCGX) announced a merger with TriGemX Bio on October 19, 2026; no transaction dollar value was disclosed. TriGemX Bio is developing elismetrep, a TRPM8…

Read
SPACs · Oct 16, 2026

SPAC Market Update October 16, 2026: PAII-Sakuu Merger Agreement, TCXB $100M IPO

Pyrophyte Acquisition Corp II (PAII) announced a merger agreement with Sakuu Corp on October 15, 2026; no transaction dollar value was disclosed. Separately, TCGX Acquisition…

Read
SPACs · Oct 15, 2026

SPAC Market Update October 15, 2026: ATII-Forge Nano Vote, OACC Redemption Update

Archimedes Tech Spac Partners Ii Co (ATII) held its Forge Nano, Inc. merger vote on October 15, 2026; no transaction dollar value was disclosed. Forge Nano develops proprietary…

Read
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer